Fig. 3From: Publication statuses of clinical trials supporting FDA-approved immune checkpoint inhibitors: a meta-epidemiological investigationDaily publications of phase 2 and 3 trials supporting the approval of new anticancer drugs (a) Daily publications of all phase 2 and 3 trials by drug type. (b) Daily publications of randomized-only phase 2 and 3 trials by drug type. ICPi, immune checkpoint inhibitorBack to article page